title: Ankle brachial index as a marker of atherosclerosis in Chinese patients with high cardiovascular risk.
abstract: To obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD), we evaluated the clinical significance of the ankle brachial index (ABI) as an indicator of PAD in Chinese patients at high cardiovascular (CV) risk. ABI was measured in 5,646 Chinese patients at high CV risk, and PAD was defined as an ABI<0.9 in either leg. Multivariable logistic regression analyses were performed to identify factors associated with PAD. A total of 5,263 patients were analyzed, 52.9% male, mean age 67.3 years, mean body mass index (BMI) 24.2 kg/m2, mean systolic/diastolic blood pressure (SBP/DBP) 139/80.7 mmHg. The prevalence of PAD in the total group of patients was 25.4%, and the prevalence was higher in females than in males (27.1% vs. 23.9%; odds ratio [OR]: 1.64). Patients with PAD were older than those without PAD (72.3+/-9.9 years vs. 65.6+/-11.7 years; OR: 1.06), and more frequently had diabetes (43.3% vs. 31.3%; OR: 2.02), coronary heart disease (CHD) (27.0% vs. 18.8%; OR: 1.67), stroke (44.4% vs. 28.3%; OR: 1.78), lipid disorders (57.2% vs. 50.7%; OR: 1.3) and a smoking habit (42.7% vs. 38.6%; OR: 1.52). The ORs for the PAD group compared with the non-PAD group demonstrated that these conditions were inversely related to ABI. Statin, angiotensin-converting enzyme-inhibitors and antiplatelet agents were only used in 40.5%, 53.6% and 69.1% of PAD patients, respectively. The data demonstrated the high prevalence and low treatment of PAD in Chinese patients at high CV risk. A lower ABI was associated with generalized atherosclerosis. Based on these findings, ABI should be a routine measurement in high risk patients. Aggressive medication was required in these patients.
authors.affiliation: Heart, Lung and Blood Vessel Center, Tongji University, Shanghai, P.R. China.
authors.forename: Buaijiaer
authors.initials: B
authors.lastname: Hasimu
authors.forename: Jue
authors.initials: J
authors.lastname: Li
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Nakayama
authors.forename: Jinming
authors.initials: J
authors.lastname: Yu
authors.forename: Jingang
authors.initials: J
authors.lastname: Yang
authors.forename: Xiankai
authors.initials: X
authors.lastname: Li
authors.forename: Dayi
authors.initials: D
authors.lastname: Hu
mesh_terms: D000368:Aged; D000842:Ankle / Q000098:blood supply* / Q000000981:diagnostic imaging; D050197:Atherosclerosis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D001794:Blood Pressure / Q000502:physiology; D001917:Brachial Plexus / Q000098:blood supply* / Q000000981:diagnostic imaging; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000453:epidemiology*; D002681:China / Q000453:epidemiology; D015897:Comorbidity; D003327:Coronary Disease / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology; D050171:Dyslipidemias / Q000453:epidemiology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D012039:Regional Blood Flow / Q000502:physiology; D012307:Risk Factors; D014463:Ultrasonography; D014652:Vascular Diseases / Q000453:epidemiology